A Phase 2, Double-Blind, Randomized Study Evaluating the Safety, Tolerability, and Efficacy of GS-4997 in Combination With Prednisolone Versus Prednisolone Alone in Subjects With Severe Alcoholic Hepatitis (AH)
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 12 Jan 2018
At a glance
- Drugs Selonsertib (Primary) ; Prednisolone
- Indications Alcoholic hepatitis
- Focus Adverse reactions
- Sponsors Gilead Sciences
- 08 Jan 2018 Status changed from recruiting to active, no longer recruiting.
- 18 Oct 2017 Planned End Date changed from 1 Apr 2018 to 1 Jun 2018.
- 18 Oct 2017 Planned primary completion date changed from 1 Jan 2018 to 1 Feb 2018.